Zynerba Pharmaceuticals Correlations
| ZYNEDelisted Stock | USD 1.30 0.04 3.17% |
The correlation of Zynerba Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Zynerba Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Zynerba Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Good diversification
The correlation between Zynerba Pharmaceuticals and NYA is -0.1 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Zynerba Pharmaceuticals and NYA in the same portfolio, assuming nothing else is changed.
Zynerba |
The ability to find closely correlated positions to Zynerba Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Zynerba Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Zynerba Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Zynerba Pharmaceuticals to buy it.
Moving together with Zynerba Stock
| 0.73 | CE | Celanese Financial Report 14th of May 2024 | PairCorr |
| 0.78 | MDH | MDH Acquisition Corp | PairCorr |
| 0.73 | XOM | Exxon Mobil Corp Sell-off Trend | PairCorr |
| 0.75 | TRV | The Travelers Companies Financial Report 18th of July 2024 | PairCorr |
| 0.92 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
| 0.84 | JPM | JPMorgan Chase Financial Report 12th of July 2024 | PairCorr |
| 0.61 | DD | Dupont De Nemours Report 7th of May 2024 | PairCorr |
| 0.79 | DIS | Walt Disney Report 8th of May 2024 | PairCorr |
| 0.81 | GE | GE Aerospace Earnings Call This Week | PairCorr |
Moving against Zynerba Stock
| 0.7 | BA | Boeing Earnings Call This Week | PairCorr |
| 0.63 | CSCO | Cisco Systems Fiscal Quarter End 30th of April 2024 | PairCorr |
| 0.54 | APAC | Stonebridge Acquisition Symbol Change | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Zynerba Stock performing well and Zynerba Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Zynerba Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| JUPW | 6.42 | 2.62 | 0.35 | (2.59) | 5.15 | 14.71 | 65.77 | |||
| SXTC | 5.34 | (0.51) | 0.00 | (0.14) | 0.00 | 10.45 | 32.91 | |||
| ACOR | 6.23 | (3.15) | 0.00 | (1.66) | 0.00 | 8.87 | 96.13 | |||
| FLGC | 6.32 | 0.30 | 0.05 | 0.40 | 5.92 | 14.42 | 51.50 | |||
| CLVR | 5.16 | 0.69 | 0.15 | 0.45 | 4.27 | 14.48 | 40.82 | |||
| IMCC | 9.14 | 1.85 | 0.20 | (1.26) | 7.33 | 29.27 | 77.51 | |||
| KHRNF | 11.05 | 2.93 | 0.10 | (0.51) | 10.91 | 50.00 | 183.33 | |||
| ALID | 11.79 | 2.16 | 0.18 | 7.85 | 9.59 | 39.09 | 91.61 | |||
| BFRI | 8.28 | 0.29 | 0.03 | 0.35 | 9.91 | 24.68 | 74.86 | |||
| TKNO | 3.89 | (0.57) | 0.00 | (0.46) | 0.00 | 7.44 | 28.78 |
View Zynerba Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Zynerba Pharmaceuticals Corporate Directors
Zynerba Pharmaceuticals corporate directors refer to members of a Zynerba Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Zynerba Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Zynerba Pharmaceuticals' board members must vote for the resolution. The Zynerba Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Daniel Kisner | Director Nominee | Profile | |
| William Federici | Director Nominee | Profile | |
| Kenneth Moch | Director Nominee | Profile | |
| Thomas Harrison | Director Nominee | Profile |
Still Interested in Zynerba Pharmaceuticals?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Zynerba Stock
If you are still planning to invest in Zynerba Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zynerba Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |